News

Filter

Human Genome/GlaxoSmithKline lupus drug Benlysta disappoints in Ph III; Updates on Seattle Genetics and Ligand milestones

21-04-2010

USA-based Human Genome Sciences and UK drug giant GlaxoSmithKline yesterday revealed top-line secondary…

Anti-Arthritics/RheumaticsAnti-viralsBenlystaBiotechnologyFinancialGenentechGeneticsGlaxoSmithKlineHuman Genome SciencesImmunologicalsLigand PharmaceuticalsPharmaceuticalResearchSeattle Genetics

Back to top